Comparison between Rossari Biotech IPO and UTI AMC IPO.
Rossari Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while UTI AMC IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Rossari Biotech IPO is up to ₹496.25 Cr whereas the issue size of the UTI AMC IPO is up to ₹2,159.88 Cr. The final issue price of Rossari Biotech IPO is ₹425.00 per share and of UTI AMC IPO is ₹554.00 per share.
| Rossari Biotech IPO | UTI AMC IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹10 per share |
| Issue Price (Lower) | ₹423.00 per share | ₹552.00 per share |
| Issue Price (Upper) | ₹425.00 per share | ₹554.00 per share |
| Issue Price (Final) | ₹425.00 per share | ₹554.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 35 shares | 27 shares |
| Fresh Issue Size | 11,76,470 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹50.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 1,05,00,000 shares | 3,89,87,081 shares |
| OFS Issue Size (Amount) | up to ₹446.25 Cr | up to ₹2,159.88 Cr |
| Issue Size Total | 1,16,76,470 shares | 3,89,87,081 shares |
| Issue Size Total (Amount) | up to ₹496.25 Cr | up to ₹2,159.88 Cr |
Rossari Biotech IPO opens on Jul 13, 2020, while UTI AMC IPO opens on Sep 29, 2020. The closing date of Rossari Biotech IPO and UTI AMC IPO is Jul 15, 2020, and Oct 01, 2020, respectively.
| Rossari Biotech IPO | UTI AMC IPO | |
|---|---|---|
| Anchor Bid Date | Jul 10, 2020 | Sep 28, 2020 |
| Issue Open | Jul 13, 2020 | Sep 29, 2020 |
| Issue Close | Jul 15, 2020 | Oct 01, 2020 |
| Basis Of Allotment (Tentative) | Jul 20, 2020 | Oct 07, 2020 |
| Initiation of Refunds (Tentative) | Jul 21, 2020 | Oct 08, 2020 |
| Credit of Share (Tentative) | Jul 22, 2020 | Oct 09, 2020 |
| Listing date (Tentative) | Jul 23, 2020 | Oct 12, 2020 |
| Anchor Lockin End date 1 | Aug 19, 2020 | Nov 06, 2020 |
| Anchor Lockin End date 2 | Oct 18, 2020 | Jan 05, 2021 |
Rossari Biotech IPO P/E ratio is 33.81, as compared to UTI AMC IPO P/E ratio of .
| Rossari Biotech IPO | UTI AMC IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 95.06 | 98.96 | ||||
| Promoter Shareholding (Post-Issue) | 73 | |||||
| P/E Ratio | 33.81 | |||||
| Market Cap | ₹2207.00 Cr. | ₹7024.01 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Rossari Biotech IPO Retail Individual Investors (RII) are offered 40,86,765 shares while in UTI AMC IPO retail investors are offered 40,86,765 shares. Qualified Institutional Buyers (QIB) are offered 23,35,294 shares in Rossari Biotech IPO and 77,57,416 shares in UTI AMC IPO.
| Rossari Biotech IPO | UTI AMC IPO | |
|---|---|---|
| Anchor Investor Reservation | 35,02,940 shares | 1,16,36,124 shares |
| Market Maker Reservation | ||
| QIB | 23,35,294 shares | 77,57,416 shares |
| NII | 17,51,471 shares | 58,18,062 shares |
| RII | 40,86,765 shares | 1,35,75,479 shares |
| Employee | 2,00,000 shares | |
| Others | ||
| Total | 1,16,76,470 shares | 3,89,87,081 shares |
Rossari Biotech IPO subscribed 79.37x in total, whereas UTI AMC IPO subscribed 2.31x.
| Rossari Biotech IPO | UTI AMC IPO | |
|---|---|---|
| QIB (times) | 85.26x | 3.34x |
| NII (times) | 239.83x | 0.93x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 7.23x | 2.32x |
| Employee (times) | 1.34x | |
| Other (times) | ||
| Total (times) | 79.37x | 2.31x |
